ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma announces launch of first generic of top selling cancer drug Revlimid
Revlimid had annual sales of .3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available in 5mg, 10mg, 15mg, and 25mg strengths. The announcement came after market hours. The Shares of Natco Pharma 2.98% to
Announcement as on 07 March 2022

Natco Pharma Standalone December 2021 Net Sales at Rs 529.50 crore, up 60.02% Y-o-Y
NULL
Announcement as on 14 February 2022

Natco Pharma consolidated net profit up 27% to Rs 80 crore in Dec quarter
The Hyderabad-based company had reported a net profit of Rs 63.4 crore in the October-December period of previous fiscal
Announcement as on 14 February 2022

Natco Pharma signs pact with MPP to sell Molnupiravir capsules
Natco Pharma has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19. MPP had taken licence from Merck Sharp & Dohme Corp (MSD), USA for t
Announcement as on 20 January 2022

Natco Pharma signs agreement with MPP to sell Molnupiravir capsules
Natco Pharma Ltd on Thursday said it has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19. MPP had taken licence from Merck Sharp & Doh
Announcement as on 20 January 2022

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 789.55
  • 12Day Average: 788.68
  • 20Day Average: 801.68
  • 50Day Average: 831.01
  • 100Day Average: 874.7
  • 150Day Average: 943.99
  • 200Day Average: 931.32

524816 Indicators & signals

Indicator MACD (12,26,9)

792.78, 806.12, -14.51
Indicator MACD is in negative zone

Indicator ADX (14)

20.75, 11.83, 18.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 782.50 780.00 to 801.15 -0.67% 0.73 times
29 Thu Oct 2026 787.75 786.00 to 799.15 -0.71% 0.66 times
28 Wed Oct 2026 793.35 779.95 to 801.85 -0.09% 2.83 times
27 Tue Oct 2026 794.05 784.65 to 798.00 0.5% 0.45 times
26 Mon Oct 2026 790.10 782.85 to 796.15 -0.27% 0.63 times
23 Fri Oct 2026 792.20 778.00 to 796.70 0.85% 1.25 times
22 Thu Oct 2026 785.50 774.00 to 789.00 0.08% 0.99 times
21 Wed Oct 2026 784.90 779.45 to 808.95 -1.98% 0.55 times
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 1.78 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.25 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.61 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 0.88 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top